Definition: collagen degradation marker found to be increased in urine in the setting of Raynaud phenomenon and systemic sclerosis (scleroderma). Reflects alterations in collagen turnover; may be useful in monitoring ongoing fibrosis in systemic sclerosis.
Disclaimer: This site is designed to offer information for general educational purposes only. The health information furnished on this site and the interactive responses are not intended to be professional advice and are not intended to replace personal consultation with a qualified physician, pharmacist, or other healthcare professional. You must always seek the advice of a professional for questions related to a disease, disease symptoms, and appropriate therapeutic treatments.
Search Stedman's Medical Dictionary
Examples: glitazone, GI cocktail, etc.
© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.